Sysmex ADR Operating Expenses 2016-2024 | SSMXY

Sysmex ADR operating expenses for the twelve months ending December 31, 2024 were $1.786B, a 14.31% decline year-over-year.

  • Sysmex ADR annual operating expenses for 2025 were $2.779B, a 9.53% increase from 2024.
  • Sysmex ADR annual operating expenses for 2024 were $2.537B, a 1.8% increase from 2023.
  • Sysmex ADR annual operating expenses for 2023 were $2.492B, a 5.5% decline from 2022.

Sysmex ADR Operating Expenses 2016-2024 | SSMXY

  • Sysmex ADR annual operating expenses for 2025 were $2.779B, a 9.53% increase from 2024.
  • Sysmex ADR annual operating expenses for 2024 were $2.537B, a 1.8% increase from 2023.
  • Sysmex ADR annual operating expenses for 2023 were $2.492B, a 5.5% decline from 2022.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$185B
Thermo Fisher Scientific (TMO)$160.4B
Edwards Lifesciences (EW)$44.7B
Alcon (ALC)$42.9B
IDEXX Laboratories (IDXX)$41.7B
DexCom (DXCM)$33B
IQVIA Holdings (IQV)$28.2B
Mettler-Toledo (MTD)$25.1B
STERIS (STE)$22.1B
Waters (WAT)$17.7B
SONOVA HOLDING (SONVY)$17B
Hologic (HOLX)$14.3B
Penumbra (PEN)$8.9B
Masimo (MASI)$8.6B
Globus Medical (GMED)$7.8B
Glaukos (GKOS)$5.7B
Teleflex (TFX)$5B
Integer Holdings (ITGR)$4B
TransMedics (TMDX)$3.8B
PROCEPT BioRobotics (PRCT)$3.3B
LivaNova (LIVN)$2.3B
Nihon Kohden (NHNKY)$2B
Veracyte (VCYT)$1.9B
Elekta AB (EKTAY)$1.9B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Pulse Biosciences (PLSE)$1.1B
Tandem Diabetes Care (TNDM)$1B